Valproic acid targets IDH1 mutants through alteration of lipid metabolism.

Saved in:
Bibliographic Details
Title: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.
Authors: Elahi LS; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Condro MC; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Kawaguchi R; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Qin Y; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Alvarado AG; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Gruender B; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Qi H; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Li T; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Lai A; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Castro MG; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA., Lowenstein PR; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA., Garrett MC; Kettering Health Network, Kettering, OH USA., Kornblum HI; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.
Source: Npj metabolic health and disease [NPJ Metab Health Dis] 2024; Vol. 2 (1), pp. 20. Date of Electronic Publication: 2024 Aug 13.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918751588706676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2948-2828 (Electronic) Linking ISSN: 29482828 NLM ISO Abbreviation: NPJ Metab Health Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2948-2828
DOI:10.1038/s44324-024-00021-6